脑机接口，重大突破！

Core Viewpoint - The article highlights significant advancements in brain-machine interface (BMI) technology in China, showcasing breakthroughs in flexible electrode arrays and clinical applications, indicating a growing investment interest and market potential in this field [1][4][6]. Group 1: Technological Breakthroughs - A research team from Northwestern Polytechnical University has developed a three-dimensional conical carbon-based flexible cortical electrode array, addressing key issues such as brain tissue damage and poor biocompatibility, and achieving international space environment technology validation [1]. - The electrode shows hundreds of times improvement in key performance metrics compared to traditional metal electrodes, ensuring long-term safety and stability for clinical applications [1]. - The article notes that 2025 is referred to as the "year of the brain-machine interface" in China, with multiple clinical trials and innovations being reported [2]. Group 2: Investment and Market Growth - Investment enthusiasm in the BMI sector has surged, with 24 financing events recorded from January to November 2025, marking a 30% year-on-year increase, and total financing exceeding 10 billion yuan over the past five years [4]. - The "14th Five-Year Plan" has identified brain-machine interfaces as one of six future industries, indicating a strategic focus on this technology as a new engine for economic growth [4]. - The BMI market in China was valued at 3.2 billion yuan in 2024, with an 18.8% year-on-year growth, projected to reach 5.58 billion yuan by 2027, reflecting a 20% growth rate [6]. Group 3: Clinical Applications and Innovations - Ming Vision Brain Machine Technology has introduced an implantable BMI visual reconstruction system, offering new possibilities for visually impaired patients [5]. - The second invasive BMI clinical trial has achieved significant progress, transitioning from 2D screen control to 3D physical world interaction [5]. - Shanghai Brain Tiger Technology has successfully completed the first clinical trial of a fully implanted, wireless, and functional BMI product, emphasizing the technology's potential to connect life and hope [5]. Group 4: Stock Market Performance - Several BMI-related stocks have experienced significant declines, with 14 stocks showing over a 20% drop from their highs, including HaiGe Communication and PuLiTe [6][7]. - In terms of profit forecasts for 2025, nine BMI-related stocks are expected to see net profit growth, with notable increases for companies like BeiLu Pharmaceutical and LePu Medical [8].